QUINAZOLINONE CHOLECYSTOKININ-B RECEPTOR LIGANDS

被引：61
|
作者：
YU, MJ
THRASHER, KJ
MCCOWAN, JR
MASON, NR
MENDELSOHN, LG
机构：
[1] Lilly Research Laboratories Eli Lilly, Company Lilly Corporate Center, Indianapolis
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 1991年 / 34卷 / 04期
关键词：
D O I：
10.1021/jm00108a040
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
[No abstract available]
引用
收藏
页码：1505 / 1508
页数：4
相关论文
共 50 条
  • [31] Expression of splice variants; The human cholecystokinin-B receptor in association with gastrointestinal cancer
    Kang, DH
    Whang, YJ
    Yoo, JH
    Song, I
    Oh, JH
    Lee, WK
    Park, HC
    Kim, SS
    Kim, JH
    GASTROENTEROLOGY, 2001, 120 (05) : A507 - A507
  • [32] Evaluation of the specificity and potency of a series of cholecystokinin-B/gastrin receptor antagonists in vivo
    Ding, XQ
    Hakanson, R
    PHARMACOLOGY & TOXICOLOGY, 1996, 79 (03): : 124 - 130
  • [33] Survival of Pancreatic Cancer is Associated with a Single Nucleotide Polymorphism of the Cholecystokinin-B Receptor
    Smith, J. P.
    Harms, J. F.
    Matters, G. L.
    McGovern, C.
    Ruggiero, F.
    Liao, J.
    Fino, K.
    Ortega, E.
    Gilius, E.
    Phillips, J., III
    PANCREAS, 2011, 40 (08) : 1354 - 1355
  • [34] Interspecies polymorphisms confer constitutive activity to the Mastomys cholecystokinin-B/gastrin receptor
    Schaffer, K
    McBride, EW
    Beinborn, M
    Kopin, AS
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (44) : 28779 - 28784
  • [35] Preclinical development of cholecystokinin-B/gastrin-receptor binding peptides.
    Behr, TM
    Behe, M
    Jenner, N
    Angerstein, C
    Gratz, S
    Becker, W
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 104P - 104P
  • [36] Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors
    Behr, TM
    Jenner, N
    Béhé, M
    Angerstein, C
    Gratz, S
    Raue, F
    Becker, W
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (06) : 1029 - 1044
  • [37] Effects of cholecystokinin-B receptor antagonist on dopamine system in tenascin mutant mice
    Fukamauchi, F
    Wang, YJ
    Mataga, N
    Kusakabe, M
    NEUROREPORT, 1997, 8 (18) : 3919 - 3922
  • [38] A single nucleotide polymorphism of the cholecystokinin-B receptor predicts risk for pancreatic cancer
    Smith, Jill P.
    Harms, John F.
    Matters, Gail L.
    McGovern, Christopher O.
    Ruggiero, Francesca M.
    Liao, Jiangang
    Fino, Kristin K.
    Ortega, Emily E.
    Gilius, Evan L.
    Phillips, John A., III
    CANCER BIOLOGY & THERAPY, 2012, 13 (03) : 164 - 174
  • [39] Identification of cholecystokinin-B/gastrin receptor domains that confer high gastrin affinity: Utilization of a novel Xenopus laevis cholecystokinin receptor
    Schmitz, F
    Prat, DS
    Wu, MJ
    Kolakowski, LF
    Beinborn, M
    Kopin, AS
    MOLECULAR PHARMACOLOGY, 1996, 50 (02) : 436 - 441
  • [40] Differential expression of gastrin, cholecystokinin-A and cholecystokinin-B receptor mRNA in human pancreatic cancer cell lines
    Monstein, HJ
    Ohlsson, B
    Axelson, J
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2001, 36 (07) : 738 - 743
12345